Follow

Submissions from 2019

Link

Re-Purposing Traditional Chinese Anti-Asthma Formula ASHMI for Triple Negative Breast Cancer, Sanjukta Chakraborty, Fei Mo, Martin Walsh, Changda Liu, Mingzhuo Cou, Rachana Maniyar, Ghada Ben Rahoma, Sarnath Singh, Tara Jarboe, Michelle Carnazza, and Raj Tiwariand Xiu-min Li (Abstract)

Link

Association of Proinflammatory and Proinsulinemic Food Groups With Maternal Postpartum Weight Retention, Jasmin Mahabamunuge, Meg Simione, Chrissy Horan, Susan Redline, Kirsten Davison, and Elsie Taveras (Abstract)

Life-Space Decline and Resilience During Lung Cancer Treatment in Older Adults, L. Metzger, L. C. Walter, C. Miaskowski, A. K. Smith, A. Hurria, J. Boscardin, H. J. Cohen, V. Lam, C. Ursem, C. M. Blakely, M. A. Gubens, T. M. Jahan, C. E. McCoach, G. M. Allen, J. Rotow, V. Musinipally, and M. L. Wong (Abstract)

Ocular Triage: A Quality Improvement Study For Referral Patients in Ophthalmology Clinic, Abhiniti Mittal and Jared Donaldson (Abstract)

Cognitive Profile in Patients with Hemodynamic Failure due to Severe Carotid Stenosis, Mathias Palmer, Randolph Marshall, Qixuan Chen, Kevin Slane, Ronald Lazar, and Marykay Pavol (Abstract)

Rate of Remission after Immunomodulatory Therapy for Uveitis, Deep Parikh, Shreyas Menon, Marta Fabrykowski, Tiffany Truong, Jason Chua, and C. Michael Samson (Abstract)

Opioid Epidemic and Headache Disorders, Urvish K. Patel, Preeti Malik, Dhaivat J. Shah, Nashmia Khan, Shivani Sharma, Saleha Saiyed, Bindi P. Chauhan, Deepkumar Patel, Ashish V. Kapoor, and Tapan R. Kavi (Abstract)

Link

Outcomes of Patients with Synchronous Head and Neck and Lung Cancers who were Treated for Cure with Multi-modality Approach, Maria L. Sandoval, A. Rimner, N. Lee, and D. Gelblum (Abstract)

Longitudinal Change in Diffusion Kurtosis Imaging Metrics as a Biomarker of Mild Traumatic Brain Injury, Teena Shetty, Joseph T. Nguyen, Esther Kim, Matthew Garvey, Taylor Cogsil, Apostolos Tsiouris, Sumit Niogi, Aashka Dalal, Kristin Halvorsen, Tianhao Zhang, Joseph Masdeu, Pratik Mukherjee, and Luca Marinelli (Abstract)

Resting State Functional Connectivity is Directly Related to Clinical Presentation of Mild Traumatic Brain Injury, Teena Shetty, Joseph T. Nguyen, Esther Kim, Matthew Garvey, Taylor Cogsil, Apostolos Tsiouris, Sumit Niogi, Aashka Dalal, Kristin Halvorsen, Tianhao Zhang, Joseph Masdeu, Pratik Mukherjee, and Luca Marinelli (Abstract)

Cognitive Impairment Screening for Older Emergency Department Patients Using Volunteers, N. Sunkara, M. Sanchez, A. Hernandez, C. Jamin, C. Caspers, C. Grudzen, S. Borson, and J. Chodosh (Abstract)

Responders to Anti-PD1 Therapy: Long-Term Outcomes and Responses to Retreatment in Melanoma (mel), Allison B. Warner, Jessica S. Palmer, Alexander N. Shoushtari, Debra A. Goldman, Katherine Panageas, Margaret K. Callahan, Jedd D. Wolchok, Michael A. Postow, and Paul B. Chapman (Abstract)

Deposits from 2018

Endothelin-1 and COMP Regulate Heme Biosynthesis and Guanylate Cyclase Expression in Smooth Muscle of Pulmonary Arteries, Norah Alruwaili, Hang Yu, Melissa R. Kelly, Dong Sun, and Michael S. Wolin (Abstract)

Therapeutic Effects of a Novel Fusion of Alt-803, an Il-15 Superagonist, with 4 Single-Chains of Anti-Cd20 Antibody (2b8t2m) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (Bl), Yaya Chu, Nang Su, Sarah Alter, Emily Jeng, Peter R. Rhode, Matthew Barth, Dean Lee, Hing C. Wong, and Mitchell S. Cairo (Abstract)

Therapeutic Effects of a Novel Fusion of Alt-803, an Il-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2b8t2m) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (Bl), Yaya Chu, Nang Kham Su, Sarah Alter, Emily K. Jeng, Peter R. Rhode, Matthew Barth, Dean A. Lee, Hing C. Wong, and Mitchell S. Cairo (Abstract)

Therapeutic Effects of a Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2B8T2M) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL), Yaya Chu, Nang Kham Su, Sarah Alter, Emily K. Jeng, Peter R. Rhode, Matthew Barth, Dean Lee, Hing C. Wong, and Mitchell S. Cairo (Abstract)

Therapeutic Effects of a Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody (2B8T2M) in Combination with Expanded Natural Killer Cells Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL), Yaya Chu, Nang Kham Su, Sarah Alter, Emily K. Jeng, Peter R. Rhode, Matthew Barth, Dean Lee, Hing C. Wong, and Mitchell S. Cairo (Abstract)

Regulation of Cytokine Release and Anti-Tumor Effect of Anti-CD20 CAR Modified Expanded Natural Killer Cells by ALT-803, an Il-15 Superagonist, Yaya Chu, Nang Kham Su, Carl Hamby, Emily K. Jeng, Sarah Alter, Matthew Barth, Hing C. Wong, Dean A. Lee, and Mitchell S. Cairo (Abstract)

Regulation of Cytokines/Chemokines Release and Anti-Tumor Effect of Expanded Natural Killer (NK) Cells By a Novel Fusion of N-820 (2B8T2M), an IL-15 Superagonist with 4 Single-Chain Anti-CD20 Antibody Domains, Against Rituximab Resistant Burkitt Lymphoma (BL), Yaya Chu, Nang Kham Su, Emily K. Jeng, Sarah Alter, Peter R. Rhode, John H. Lee, Gaurav Nayyar, Matthew Barth, Dean A. Lee, Hing C. Wong, and Mitchell S. Cairo (Abstract)

2B8T2M, A Novel Fusion of ALT-803, an IL-15 Superagonist, with 4 Single-Chains of Anti-CD20 Antibody Significantly Enhanced Expanded Natural Killer Cells Ctotoxicity Against Rituximab Sensitive and Resistant Burkitt Lymphoma (BL), Yaya Chu, Nang Kham Su, Emily K. Jeng, Sarah Alter, Peter R. Rhode, Gaurav Nayyar, Matthew Barth, Dean A. Lee, Hing C. Wong, and Mitchell S. Cairo (Abstract)

Acute Stemi Due to Mechanical AV Thrombosis in Light of Noncompliance With Anticoagulation Therapy, Bader Abu Ghalyoun, Lucas Bazi, Matthew Lempel, Dema Shamoon, and Fayez Shamoon (Abstract)

Otalgia Due to Vertebral Artery Dissection, Vaibhav Goswami, Jacob Perlman, Jazmine Liew, Scott Woolf, and Ramandeep Sahni (Abstract)

Deposits from 2016

Link

Programmed Death Ligand-1 (PD-L1) Expression in Operable Non-Small Cell Lung Cancer (NSCLC) by Immunohistochemical Analysis, Sabina Babayeva, Arteni Dyatlov, Ranjita Pallavi, Michael P. Fanucchi, Carmelo Puccio, Rocco J. Lafaro, Fouzia Shakil, John T. Fallon, and Minghao Zhong (Abstract)